In order to provide a molecular target for early diagnosis and treatment of thyroid cancer, here, we examined the role of USP10 against ABCG2-mediated malignant biological behavior of DOX-resistant thyroid cancer cells and shed light on the molecular mechanism by which USP10 mediated these processes. This evidence concerns the gene USP10 and thyroid gland carcinoma.